NEW YORK — Bruker said on Friday that it has received CE-IVD marking for its FluoroType SARS-CoV-2/Flu/RSV winter respiratory virus panel.
The PCR-based panel is designed to simultaneously detect SARS-CoV-2, influenza A and B, and respiratory syncytial virus in nasopharyngeal swabs, oropharyngeal swabs, and saliva samples, according to the Billerica, Massachusetts-based company.
The test kit comes with reagents to generate up to 96 result panels in less than two hours following nucleic acid extraction.